Ayurvedic Treatment in refractory and chronic migraine patients
Phase 3
Completed
- Conditions
- Health Condition 1: G00-G99- Diseases of the nervous system
- Registration Number
- CTRI/2019/05/018980
- Lead Sponsor
- Ipca Laboratories Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 157
Inclusion Criteria
Male or Female patients age 18-65 years
Exclusion Criteria
Patients having migraine with aura, sinusitis induced headache, patients with refractory headache, post traumatic headache, medication over use headache, intracranial hypertension/hypotension and neuralgias and patient with pseudo refractory migraines
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean change in number of headache daysTimepoint: The Aurvedic treatment protocol will be given for 120 days and the patients will be then followed up every month for the next 360 days.
- Secondary Outcome Measures
Name Time Method To assess the efficacy in reducing the intensity and frequency of pain and associated symptoms on migraine patients by using modern scientific parameters (VAS & MIDAS)Timepoint: 7 visits to complete 1 year